Dong Jiali, Li Yuan, Xiao Huiwen, Cui Ming, Fan Saijun
Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China.
Department of Microbiology, College of Life Sciences, Nankai University, Tianjin 300071, China.
Cancer Biol Med. 2021 Aug 9;19(1):43-55. doi: 10.20892/j.issn.2095-3941.2020.0476.
The human microflora is a complex ecosystem composed of diverse microorganisms mainly distributed in the epidermal and mucosal habitats of the entire body, including the mouth, lung, intestines, skin, and vagina. These microbial communities are involved in many essential functions, such as metabolism, immunity, host nutrition, and diseases. Recent studies have focused on the microbiota associated with cancers, particularly the oral and intestinal microbiota. Radiotherapy, the most effective cytotoxic modality available for solid tumors, contributes to the treatment of cancer patients. Mounting evidence supports that the microbiota plays pivotal roles in the efficacy and prognosis of tumor radiotherapy. Here, we review current research on the microbiota and cancer development, and describe knowledge gaps in the study of radiotherapy and the microbiota. Better understanding of the effects of the microbiome in tumorigenesis and radiotherapy will shed light on future novel prevention and treatment strategies based on modulating the microbiome in cancer patients.
人类微生物群是一个复杂的生态系统,由多种微生物组成,主要分布在全身的表皮和粘膜栖息地,包括口腔、肺部、肠道、皮肤和阴道。这些微生物群落参与许多重要功能,如新陈代谢、免疫、宿主营养和疾病。最近的研究集中在与癌症相关的微生物群,特别是口腔和肠道微生物群。放射疗法是实体瘤最有效的细胞毒性治疗方式,有助于癌症患者的治疗。越来越多的证据支持微生物群在肿瘤放射治疗的疗效和预后中起关键作用。在此,我们综述了目前关于微生物群与癌症发展的研究,并描述了放射治疗与微生物群研究中的知识空白。更好地理解微生物组在肿瘤发生和放射治疗中的作用,将为未来基于调节癌症患者微生物组的新型预防和治疗策略提供线索。